Holen Sie sich die Stockscreener-App
235.80
0.87%
2.03
Handel nachbörslich:
235.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$233.77
Offen:
$233.07
24-Stunden-Volumen:
2.84M
Relative Volume:
1.27
Marktkapitalisierung:
$55.23B
Einnahmen:
$250.74B
Nettoeinkommen (Verlust:
$1.55B
KGV:
36.06
EPS:
6.5398
Netto-Cashflow:
$4.39B
1W Leistung:
-1.31%
1M Leistung:
+9.02%
6M Leistung:
+17.25%
1J Leistung:
+45.40%
1-Tages-Spanne:
$232.05
$236.26
1-Wochen-Bereich:
$231.83
$243.21
52-Wochen-Spanne:
$137.75
$243.21
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
235.80 | 55.23B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
805.96 | 94.36B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
303.44 | 59.04B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
84.40 | 9.61B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.52 | 1.30B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health stock holds steady on its distributor scale - ad-hoc-news.de
Cardinal Health stock holds steady as distribution and specialty services drive long-term value - ad-hoc-news.de
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s - Morningstar
Should You Retain CAH Stock After Removal From Several Russell Indices? - TradingView
TD Cowen Adjusts Price Target on Cardinal Health to $275 From $255 - Moomoo
TD Cowen Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $275 - Moomoo
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11 - Cardinal Health
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cardinal Health focuses on core distribution and services as investors track the S&P 500 component - ad-hoc-news.de
Cardinal Health Kangaroo OMNI Enteral Feeding PumpB2B workhorse for US hospitals - AD HOC NEWS
Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)? - Yahoo Finance
Evercore ISI Adjusts Price Target on Cardinal Health to $265 From $240 - Moomoo
Cardinal Health drops after Q4 results; allocates $1.9B for Solaris Health acquisition - MSN
Cardinal Health holds steady as investors await a new catalyst. - ad-hoc-news.de
Cardinal Health stock hits all-time high at 241.86 USD By Investing.com - Investing.com Canada
Cardinal Health stock hits all-time high at 241.86 USD - Investing.com
Cardinal Health, Inc. (CAH) Stock Analysis: Stellar Revenue Growth and Analyst Enthusiasm Propel Market Sentiment - DirectorsTalk Interviews
Cardinal Health focuses on distribution strength amid evolving healthcare demand - ad-hoc-news.de
Cardinal Health strengthens its role in U.S. drug distribution as investors weigh long-term margins - ad-hoc-news.de
Cardinal Health Kangaroo Joey Enteral Feeding PumpA long-running workhorse in U.S. hospitals - ad-hoc-news.de
Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done” - Yahoo Finance
Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal? - Sahm
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating - Seeking Alpha
Enterprise value to revenue forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $248.27, Implies 4% Upside - TradingView
BofA Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $260 - Moomoo
Price to sales forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Price to earnings forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Why Is Cardinal Health (NYSE:CAH) A Value Stock In Focus? - Kalkine Media
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health opens the week with analyst focus, shares in S&P 500 healthcare - AD HOC NEWS
The Kangaroo ePump Enteral Feeding Pump from Cardinal Health Inc.quiet bedside workhorse with pre - AD HOC NEWS
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Cardinal Health, Inc.(NYSE: CAH) dropped from Russell 1000 Defensive Index - marketscreener.com
Cardinal Health opens the week with earnings calendar, shares steady - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and Revenue Growth Propel Healthcare Giant Forward - DirectorsTalk Interviews
Enterprise value to EBIT forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade) - Seeking Alpha
Cardinal Health opens the week with strong momentum, shares extend sector outperformance - AD HOC NEWS
Cardinal Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 1 Sh - TradingView
Enterprise value to EBITDA forward of Cardinal Health, Inc. – NYSE:CAH - TradingView
Sureties SureStep Podiatry Instruments from Cardinal Health Inc.single-use focus in foot care - AD HOC NEWS
Cardinal Health charts a technical range, shares sit between key support and resistance - AD HOC NEWS
Cardinal Health, Inc. Actuals & Estimates (NYSE:CAH) - TradingView
Why the Market Dipped But Cardinal Health (CAH) Gained Today - Yahoo Finance
Cardinal Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cardinal Health hits fresh high, shares ride strong health care momentum - AD HOC NEWS
Cardinal Health, Inc. (CAH) hits fresh high: Is there still room to run? - MSN
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):